In December, Howard Marks published an investment memo titled, “Is it a bubble?” that expressed some of his skepticism and reservations about artificial intelligence and the stock-market boom it had ...

Howard Marks is much less skeptical about AI than he was just a few months ago. In December, Howard Marks published an investment memo titled, "Is it a bubble?" that expressed some of his skepticism ...

NEW YORK, Jan. 27, 2026 /PRNewswire/ -- August today announced a two-week free trial to its platform and August Academy, a comprehensive library of over 100 video tutorials and lessons designed to ...

Self-serve platform removes traditional barriers of cost, implementation, and training that have kept powerful AI tools out of reach for most legal practices NEW YORK, Jan. 27, 2026 /PRNewswire/ -- ...

JPMorgan initiated coverage on Vor Biopharma (NASDAQ:VOR) with an Overweight rating and $43 price target, representing over 400% upside from current levels The investment bank views telitacicept, a ...

The VOR X RWY 10 at TNCM is incorrectly read by the FMC and incorrectly displayed - NAV mode cannot be used to fly approach. Programme the TNCM VOR X approach to TNCM through PJM. When comparing ...

Vor Biopharma Inc. (VOR) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

I love being a licensed private pilot. As you may have seen from other videos, I am starting my instrument rating training. I really believe that I will be a much safer pilot when I get my IFR or ...

Vor Bio's stock rises after RemeGen’s Phase 3 trial of telitacicept meets the primary endpoint. Telitacicept showed safety and reduced disease activity in Sjögren's patients. Up Next: Wall Street ...

FRIDAY: A customer flew in from Lubbock for a couple of VOR approaches, then back in his Piper Cherokee 180. Mark Parish flew locally in his Cessna 182 Skylane. Med-Trans flew over to Covenant Health ...